Intra-articular lentivirus-mediated gene therapy targeting CRACM1 for the treatment of collagen-induced arthritis.
暂无分享,去创建一个
[1] M. Fujii,et al. Defective splicing of the background K+ channel K2P5.1 by the pre-mRNA splicing inhibitor, pladienolide B in lectin-activated mouse splenic CD4+ T cells. , 2016, Journal of pharmacological sciences.
[2] M. Kuno,et al. CRACM3 regulates the stability of non-excitable exocytotic vesicle fusion pores in a Ca2+-independent manner via molecular interaction with syntaxin4 , 2016, Scientific Reports.
[3] Feng Cai,et al. Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis. , 2016, Journal of pharmacological sciences.
[4] K. Maeyama,et al. Systemic Lentivirus-Mediated Delivery of Short Hairpin RNA Targeting Calcium Release–Activated Calcium Channel 3 as Gene Therapy for Collagen-Induced Arthritis , 2015, The Journal of Immunology.
[5] K. Moudgil,et al. Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy , 2014, International journal of molecular sciences.
[6] A. Schambach,et al. Safety of gene therapy: new insights to a puzzling case. , 2014, Current gene therapy.
[7] M. Kuno,et al. Upregulation of store‐operated Ca2+ entry in the naïve CD4+ T cells with aberrant cytokine releasing in active rheumatoid arthritis , 2014, Immunology and cell biology.
[8] J. Ting,et al. HIV-1 Infection Induces Interleukin-1β Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes* , 2014, The Journal of Biological Chemistry.
[9] P. Robbins,et al. Arthritis gene therapy and its tortuous path into the clinic. , 2013, Translational research : the journal of laboratory and clinical medicine.
[10] M. Prakriya. Store-operated Orai channels: structure and function. , 2013, Current topics in membranes.
[11] S. Akira,et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. , 2012, Cell host & microbe.
[12] David H. Salinger,et al. A dose–response Meta‐Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis , 2011, Clinical pharmacology and therapeutics.
[13] R. Rickert,et al. Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis , 2011, Nature Protocols.
[14] A. Parekh. Store-operated CRAC channels: function in health and disease , 2010, Nature Reviews Drug Discovery.
[15] Ashley M. Miller,et al. Mast cells express IL-17A in rheumatoid arthritis synovium. , 2010, Journal of immunology.
[16] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[17] M. Beaven,et al. Regulation of Ca2+ signaling with particular focus on mast cells. , 2009, Critical reviews in immunology.
[18] Y. Shimizu,et al. Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. , 2008, International immunopharmacology.
[19] Y. Kadono,et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.
[20] J. Kay,et al. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. , 2004, Rheumatology.